| scholarly article | Q13442814 |
| P2093 | author name string | S Andersson | |
| M Mints | |||
| S Souchelnytskyi | |||
| S Attarha | |||
| P2860 | cites work | Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress | Q24310874 |
| A novel inducible transactivation domain in the androgen receptor: implications for PRK in prostate cancer | Q24338270 | ||
| Comprehensive molecular portraits of human breast tumours | Q24630844 | ||
| Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine | Q27024626 | ||
| Regulation of microfilament reorganization and invasiveness of breast cancer cells by kinase dead p21-activated kinase-1 | Q28141931 | ||
| The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models | Q28212902 | ||
| Downregulation of p21-activated kinase-1 inhibits the growth of gastric cancer cells involving cyclin B1 | Q28252336 | ||
| Protein interaction networks from yeast to human | Q30002395 | ||
| PRK1 distribution in normal tissues and carcinomas: overexpression and activation in ovarian serous carcinoma | Q30434644 | ||
| Proteomics reveals protein profile changes in cyclooxygenase-2 inhibitor-treated endometrial cancer cells | Q33437632 | ||
| Meta-data analysis as a strategy to evaluate individual and common features of proteomic changes in breast cancer. | Q33810860 | ||
| Integration of Next-Generation Sequencing Into Clinical Practice: Are We There Yet? | Q34144944 | ||
| Microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma | Q34287768 | ||
| Ontologies for proteomics: towards a systematic definition of structure and function that scales to the genome level | Q35053330 | ||
| Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium | Q35909215 | ||
| Personalized therapy in endometrial cancer: Challenges and opportunities | Q35911350 | ||
| Bridging proteomics and systems biology: what are the roads to be traveled? | Q36273103 | ||
| Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives | Q36386428 | ||
| Novel molecular profiles of endometrial cancer-new light through old windows. | Q37025301 | ||
| Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation | Q37140110 | ||
| Systems biology approaches to disease marker discovery | Q37763815 | ||
| Emerging therapeutic targets in endometrial cancer | Q37827340 | ||
| Markers for individualised therapy in endometrial carcinoma | Q38030768 | ||
| Pak-1 expression increases with progression of colorectal carcinomas to metastasis | Q38447605 | ||
| Full-length Mst1 exhibits growth promoting function in human hepatocellular carcinoma cells. | Q39205350 | ||
| Guidelines for the next 10 years of proteomics | Q40359492 | ||
| Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study | Q44697724 | ||
| Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors | Q44827392 | ||
| Identification of a gene expression signature for survival prediction in type I endometrial carcinoma | Q51552563 | ||
| Pathologic expression of p53 or p16 in preoperative curettage specimens identifies high-risk endometrial carcinomas | Q53256024 | ||
| Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer. | Q54558046 | ||
| Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer | Q70012270 | ||
| Prognostic significance of hormone receptors in endometrial cancer | Q70557984 | ||
| Elevated Plasma Growth Differentiation Factor-15 Correlates with Lymph Node Metastases and Poor Survival in Endometrial Cancer | Q84204747 | ||
| Endometrial cancer and application of proteomics | Q85009585 | ||
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 704-713 | |
| P577 | publication date | 2013-07-09 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Individualised proteome profiling of human endometrial tumours improves detection of new prognostic markers | |
| P478 | volume | 109 |
| Q38187679 | Cancer biomarker discovery: current status and future perspectives. |
| Q31148183 | Classical MALDI-MS versus CE-based ESI-MS proteomic profiling in urine for clinical applications |
| Q34028421 | PKN1 modulates TGFβ and EGF signaling in HEC-1-A endometrial cancer cell line |
| Q92744508 | Proteomic analysis of malignant and benign endometrium according to obesity and insulin-resistance status using Reverse Phase Protein Array |
| Q53089693 | Report on the International Workshop 'Cancer stem cells: the mechanisms of radioresistance and biomarker discovery'. |
| Q37195268 | Two Cases of Endometrial Cancer in Twin Sisters with Myotonic Dystrophy. |
Search more.